{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:27:33Z","timestamp":1781105253317,"version":"3.54.1"},"reference-count":48,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1297\/cpe.2023-0081","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T17:11:42Z","timestamp":1708621902000},"page":"87-93","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes mellitus with severe insulin resistance in a young male patient with          a heterozygous pathogenic &lt;i&gt;IRS1&lt;\/i&gt; frameshift          variant"],"prefix":"10.1297","volume":"33","author":[{"given":"Yamato","family":"Osawa","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Child Health, Nihon University School of              Medicine, Tokyo, Japan"},{"name":"Department of Pediatrics, Kobari General Hospital, Chiba,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Ichiwata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Nihon University School of              Medicine, Tokyo, Japan"},{"name":"Department of Pediatrics, Kobari General Hospital, Chiba,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kenmotsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobari General Hospital, Chiba,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okada Hospital, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Masunaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine,              Hamamatsu, Japan"},{"name":"Department of Regional Medical Care Support, Hamamatsu University School of              Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamamatsu University School of Medicine,              Hamamatsu, Japan"},{"name":"Department of Biochemistry, Hamamatsu University School of Medicine,              Hamamatsu, Japan"},{"name":"Department of Pediatrics, Hamamatsu Medical Center, Hamamatsu,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Nihon University School of              Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Urakami","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Nihon University School of              Medicine, Tokyo, Japan"},{"name":"Department of Pediatrics, Kobari General Hospital, Chiba,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Michael,                MD,                Kulkarni,              RN, Postic,                C, Previs,                SF,              Shulman, GI,                Magnuson,              MA, et al.            Loss of insulin signaling in hepatocytes leads to severe insulin            resistance and progressive hepatic dysfunction. Mol            Cell          2000;6: 87\u201397.","DOI":"10.1016\/S1097-2765(05)00015-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Esposito,                DL, Li,                Y, Cama,                A, Quon,                MJ. Tyr(612)            and Tyr(632) in human insulin receptor substrate-1 are important for full activation of            insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in            adipose cells. Endocrinology          2001;142: 2833\u201340.","DOI":"10.1210\/endo.142.7.8283"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shimomura,                I, Matsuda,                M, Hammer,                RE,                Bashmakov,              Y, Brown,                MS,                Goldstein,              JL. Decreased            IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers            of lipodystrophic and ob\/ob mice. Mol Cell          2000;6: 77\u201386.","DOI":"10.1016\/S1097-2765(05)00010-9"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sun,              XJ,                Rothenberg,              P, Kahn,                CR, Backer,                JM, Araki,                E, Wilden,                PA, et al.            Structure of the insulin receptor substrate IRS-1 defines a unique signal            transduction protein. Nature          1991;352: 73\u20137.","DOI":"10.1038\/352073a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kubota,              T, Kubota,                N,              Kadowaki,            T. Imbalanced            insulin actions in obesity and type 2 diabetes: Key mouse models of insulin signaling            pathway. Cell Metab          2017;25: 797\u2013810.","DOI":"10.1016\/j.cmet.2017.03.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Almind,              K, Bj\u00f8rbaek,                C,                Vestergaard,              H, Hansen,                T, Echwald,                S,              Pedersen,            O. Aminoacid            polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes            mellitus. Lancet          1993;342: 828\u201332.","DOI":"10.1016\/0140-6736(93)92694-O"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Laakso,              M, Malkki,                M,                Kek\u00e4l\u00e4inen,              P, Kuusisto,                J, Deeb,                SS. Insulin            receptor substrate-1 variants in non-insulin-dependent diabetes.            J Clin Invest          1994;94: 1141\u20136.","DOI":"10.1172\/JCI117429"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Imai,              Y, Fusco,                A, Suzuki,                Y, Lesniak,                MA,                D\u2019Alfonso,              R, Sesti,                G, et al.            Variant sequences of insulin receptor substrate-1 in patients with            noninsulin-dependent diabetes mellitus. J Clin Endocrinol            Metab          1994;79: 1655\u20138.","DOI":"10.1210\/jcem.79.6.7989470"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Ura,              S, Araki,                E,                Kishikawa,              H, Shirotani,                T, Todaka,                M, Isami,                S, et al.            Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in            Japanese patients with NIDDM: identification of five novel          polymorphisms. Diabetologia          1996;39: 600\u20138.","DOI":"10.1007\/BF00403308"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yoshimura,                R, Araki,                E, Ura,                S, Todaka,                M,              Tsuruzoe, K,                Furukawa,            N, et al.            Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1            in the PTB domain and near SH2 protein binding sites result in impaired function at            different steps of IRS-1 signaling. Diabetes          1997;46: 929\u201336.","DOI":"10.2337\/diabetes.46.6.929"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Imai,              Y, Philippe,                N, Sesti,                G, Accili,                D, Taylor,                SI.            Expression of variant forms of insulin receptor substrate-1 identified in            patients with noninsulin-dependent diabetes mellitus. J Clin            Endocrinol Metab          1997;82: 4201\u20137.","DOI":"10.1210\/jc.82.12.4201"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Almind,              K, Inoue,                G,              Pedersen, O,                Kahn,            CR. A common            amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin            signaling. Evidence from transfection studies. J Clin            Invest          1996;97: 2569\u201375.","DOI":"10.1172\/JCI118705"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shinagawa,                T, Ishii,                S. Generation            of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II            promoter. Genes Dev          2003;17: 1340\u20135.","DOI":"10.1101\/gad.1073003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rubinson,                DA, Dillon,                CP,                Kwiatkowski,              AV, Sievers,                C, Yang,                L, Kopinja,                J, et al.            A lentivirus-based system to functionally silence genes in primary            mammalian cells, stem cells and transgenic mice by RNA interference.            Nat Genet          2003;33: 401\u20136.","DOI":"10.1038\/ng1117"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kasim,              V, Miyagishi,                M, Taira,                K. Control of            siRNA expression using the Cre-loxP recombination system.            Nucleic Acids Res          2004;32: e66.","DOI":"10.1093\/nar\/gnh061"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sesti,              G, Federici,                M, Hribal,                ML, Lauro,                D,              Sbraccia, P,                Lauro,            R. Defects of the            insulin receptor substrate (IRS) system in human metabolic disorders.            FASEB J          2001;15: 2099\u2013111.","DOI":"10.1096\/fj.01-0009rev"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. El                Mkadem, SA,                Lautier, C,                Macari, F,                Molinari,            N, Lef\u00e8bvre,                P, Renard,                E, et al.            Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in            moderate-to-severe insulin resistance of women with polycystic ovary            syndrome. Diabetes          2001;50: 2164\u20138.","DOI":"10.2337\/diabetes.50.9.2164"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kovacs,              P, Hanson,                RL, Lee,                YH, Yang,                X, Kobes,                S, Permana,                PA, et al.            The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes            in Pima Indians. Diabetes          2003;52: 3005\u20139.","DOI":"10.2337\/diabetes.52.12.3005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Esposito,                DL, Li,                Y, Vanni,                C,                Mammarella,              S, Veschi,                S, Della                Loggia, F, et            al. A novel T608R missense mutation in insulin            receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic            insulin signaling. J Clin Endocrinol Metab          2003;88: 1468\u201375.","DOI":"10.1210\/jc.2002-020933"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Villuendas,                G,                Botella-Carretero,              JI, Rold\u00e1n,                B, Sancho,                J,                Escobar-Morreale,              HF, San                Mill\u00e1n, JL.            Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the            insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass            index in women with polycystic ovary syndrome and non-hyperandrogenic            controls. Hum Reprod          2005;20: 3184\u201391.","DOI":"10.1093\/humrep\/dei205"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rung,              J, Cauchi,                S,                Albrechtsen,              A, Shen,                L,                Rocheleau,              G,                Cavalcanti-Proen\u00e7a,              C, et al.            Genetic variant near IRS1 is associated with type 2 diabetes, insulin            resistance and hyperinsulinemia. Nat Genet          2009;41: 1110\u20135.","DOI":"10.1038\/ng.443"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yousef,              AA, Behiry,                EG, Allah,                WMA,                Hussien,            AM,              Abdelmoneam,              AA, Imam,                MH, et al.            IRS-1 genetic polymorphism (r.2963G&gt;A) in type 2 diabetes mellitus            patients associated with insulin resistance. Appl Clin            Genet          2018;11: 99\u2013106.","DOI":"10.2147\/TACG.S171096"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kato,              N, Takimoto,                H, Sudo,                N. The cubic            functions for spline smoothed L, S and M values for BMI reference data of Japanese            children. Clin Pediatr Endocrinol          2011;20: 47\u20139.","DOI":"10.1297\/cpe.20.47"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Masunaga,                Y,                Nishimura,              G, Takahashi,                K,                Hishiyama,              T, Imamura,                M,                Kashimada,              K, et al.            Clinical and molecular findings in three Japanese patients with            N-acetylneuraminic acid synthetase-congenital disorder of glycosylation            (NANS-CDG). Sci Rep          2022;12: 17079.","DOI":"10.1038\/s41598-022-21751-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Richards,                S, Aziz,                N, Bale,                S, Bick,                D, Das,                S,                Gastier-Foster,              J, et al.            ACMG Laboratory Quality Assurance Committee.            Standards and guidelines for the interpretation of sequence variants: a            joint consensus recommendation of the American College of Medical Genetics and Genomics            and the Association for Molecular Pathology. Genet Med          2015;17: 405\u201324.","DOI":"10.1038\/gim.2015.30"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kuzmiak,                HA, Maquat,                LE. Applying            nonsense-mediated mRNA decay research to the clinic: progress and            challenges. Trends Mol Med          2006;12: 306\u201316.","DOI":"10.1016\/j.molmed.2006.05.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Whitehead,                JP,                Humphreys,              P, Krook,                A, Jackson,                R, Hayward,                A, Lewis,                H, et al.            Molecular scanning of the insulin receptor substrate 1 gene in subjects            with severe insulin resistance: detection and functional analysis of a naturally            occurring mutation in a YMXM motif. Diabetes          1998;47: 837\u20139.","DOI":"10.2337\/diabetes.47.5.837"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hribal,              ML, Federici,                M, Porzio,                O, Lauro,                D, Borboni,                P, Accili,                D, et al.            The Gly--&gt;Arg972 amino acid polymorphism in insulin receptor            substrate-1 affects glucose metabolism in skeletal muscle cells.            J Clin Endocrinol Metab          2000;85: 2004\u201313.","DOI":"10.1210\/jc.85.5.2004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Porzio,              O, Federici,                M, Hribal,                MI, Lauro,                D, Accili,                D, Lauro,                R, et al.              Gly\u2192Arg<sup>972<\/sup> amino acid polymorphism in insulin receptor            substrate 1 impairs insulin secretion in pancreatic beta cells.            J Clin Invest          1999;104: 357\u201364.","DOI":"10.1172\/JCI5870"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Federici,                M, Hribal,                ML,              Ranalli, M,                Marselli,            L, Porzio,                O, Lauro,                D, et al.            The common Arg972 polymorphism in insulin receptor substrate-1 causes            apoptosis of human pancreatic islets. FASEB J          2001;15: 22\u20134.","DOI":"10.1096\/fj.00-0414fje"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Herman,              R, Kravos,                NA,                Jensterle,              M, Jane\u017e,                A, Dol\u017ean,                V. Metformin            and insulin resistance: a review of the underlying mechanisms behind changes in            GLUT4-mediated glucose transport. Int J Mol Sci          2022;23: 1264.","DOI":"10.3390\/ijms23031264"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Atabek,              ME, Pirgon,                O. Use of            metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized,            double-blind, placebo-controlled clinical trial. J Pediatr            Endocrinol Metab          2008;21: 339\u201348.","DOI":"10.1515\/JPEM.2008.21.4.339"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Worsley,              R, Jane,                F,              Robinson, PJ,                Bell, RJ,                Davis,            SR. Metformin for            overweight women at midlife: a double-blind, randomized, controlled            trial. Climacteric          2015;18: 270\u20137.","DOI":"10.3109\/13697137.2014.954997"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pala,              L, Barbaro,                V,                Dicembrini,              I, Rotella,                CM. The            therapy of insulin resistance in other diseases besides type 2 diabetes.            Eat Weight Disord          2014;19: 275\u201383.","DOI":"10.1007\/s40519-014-0139-y"},{"key":"35","unstructured":"35. Nawrocka-Rutkowska,                J,              Cie\u0107wie\u017c, S,                Marciniak,              A, Brodowska,                A,                Wi\u015bniewska,              B, Kotlega,                D, et al.            Insulin resistance assessment in patients with polycystic ovary syndrome            using different diagnostic criteria--impact of metformin treatment.            Ann Agric Environ Med          2013;20: 528\u201332."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kamenova,                P.            Therapeutic potential of metformin in normal glucose tolerant persons            with Reyes metabolic syndrome. Biotechnol Equip.          2020;34: 30\u20137.","DOI":"10.1080\/13102818.2019.1711184"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Giannarelli,                R, Aragona,                M,              Coppelli, A,                Del Prato,              S. Reducing            insulin resistance with metformin: the evidence today. Diabetes            Metab          2003;29: S28\u201335.","DOI":"10.1016\/S1262-3636(03)72785-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ghaffari,                M, Payami,                S, Payami,                S,                Ashtary-Larky,              D, Nikzamir,                A,                Mohammadzadeh,              G. Evaluation            of insulin resistance indices in type 2 diabetic patients treated with different            anti-diabetic drugs. Open J Endocr Metab Dis          2016;6: 95\u2013101.","DOI":"10.4236\/ojemd.2016.62013"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Bjornstad,                P, Sch\u00e4fer,                M, Truong,                U,                Cree-Green,              M, Pyle,                L,                Baumgartner,              A, et al.            Metformin improves insulin sensitivity and vascular health in youth with            type 1 diabetes mellitus. Circulation          2018;138: 2895\u2013907.","DOI":"10.1161\/CIRCULATIONAHA.118.035525"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Staels,              B. Metformin            and pioglitazone: Effectively treating insulin resistance. Curr            Med Res Opin          2006;22(Suppl 2):            S27\u201337.","DOI":"10.1185\/030079906X112732"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Takeuchi,                T,              Ishigaki, Y,                Hirota, Y,                Hasegawa,            Y, Yorifuji,                T,              Kadowaki, H,              et al. Clinical characteristics of insulin            resistance syndromes: A nationwide survey in Japan. J Diabetes            Investig          2020;11: 603\u201316.","DOI":"10.1111\/jdi.13171"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Hosokawa,                Y, Ogawa,                W. SGLT2            inhibitors for genetic and acquired insulin resistance: Considerations for clinical            use. J Diabetes Investig          2020;11: 1431\u20133.","DOI":"10.1111\/jdi.13309"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Kawana,              Y, Imai,                J, Sawada,                S, Yamada,                T,              Katagiri,            H. Sodium-glucose            cotransporter 2 inhibitor improves complications of lipodystrophy: a case            report. Ann Intern Med          2017;166: 450\u20131.","DOI":"10.7326\/L16-0372"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Hamaguchi,                T, Hirota,                Y,              Takeuchi, T,                Nakagawa,            Y, Matsuoka,                A,                Matsumoto,              M, et al.            Treatment of a case of severe insulin resistance as a result of a PIK3R1            mutation with a sodium-glucose cotransporter\u00a02 inhibitor. J            Diabetes Investig          2018;9: 1224\u20137.","DOI":"10.1111\/jdi.12825"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Nagashima,                S,                Wakabayashi,              T, Saito,                N,                Takahashi,              M, Okada,                K, Ebihara,                K, et al.            Long-term efficacy of the sodium-glucose cotransporter\u00a02 inhibitor,            ipragliflozin, in a case of type\u00a0A insulin resistance syndrome.            J Diabetes Investig          2020;11: 1363\u20135.","DOI":"10.1111\/jdi.13241"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Park,              HJ, Kim,                SK, Kang,                WS, Park,                JK, Kim,                YJ, Nam,                M, et al.            Association between IRS1 gene polymorphism and autism spectrum disorder:            a pilot case-control study in Korean males. Int J Mol            Sci          2016;17: 1227.","DOI":"10.3390\/ijms17081227"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Li,                N, Zhou,                T, Fei,                E. Actions of            metformin in the brain: A new perspectives of metformin treatments in related            neurological disorders. Int J Mol Sci          2022;23: 8281.","DOI":"10.3390\/ijms23158281"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Cao,              G, Gong,                T, Du,                Y, Wang,                Y, Ge,                T, Liu,                J. Mechanism            of metformin regulation in central nervous system: Progression and future            perspectives. Biomed Pharmacother          2022;156: 113686.","DOI":"10.1016\/j.biopha.2022.113686"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/2\/33_2023-0081\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T01:05:46Z","timestamp":1711760746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/33\/2\/33_2023-0081\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2023-0081","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2023-0081"}}